Breaking News, Promotions & Moves

Bayer Adds Senior Leadership Role

Immergut to serve as VP and head of communications

By: Kristin Brooks

Managing Editor, Contract Pharma

Steven Immergut has been appointed to the newly created senior position, vice president and head of communications, Bayer HealthCare Pharmaceuticals. Mr. Immergut will report directly to Raymond F. Kerins, Jr., senior vice president and head of communications, Government Relations and Policy for Bayer Corp., and will serve on the U.S. Communications, Government Relations and Policy Leadership Team.
 
Mr. Immergut spent the last three years in senior roles at the U.S. FDA, most recently as Acting Associate Commissioner for External Affairs. In this new role, he’ll be responsible for developing and executing external and internal communication strategies for Bayer’s pharmaceutical portfolio in U.S. He will be based in Washington, D.C., with regular travel to Whippany, NJ.  
 
In his most recent role at the FDA, Mr. Immergut directed communications and media on a wide range of regulatory and educational activities and issues, enhanced stakeholder relationships, and helped FDA continue to transform its website and blog into meaningful channels of communication. Also, for two years he served as Assistant Commissioner for Media Affairs, leading the agency’s interactions with the news media. Prior to his FDA service, Mr. Immergut managed government and private sector health communications activities for the management consulting firm Booz Allen Hamilton.     
 
“I am delighted to have Steven join the Bayer team as we continue to raise Bayer’s profile in the United States and advance our goal of  ‘Science For A Better Life,’ ” said Mr. Kerins. “Steven’s unparalleled healthcare communications experience, together with his knowledge of the regulatory environment and public health expertise, will be tremendous assets to Bayer. I look forward to working with him closely as we advance communications about our pharmaceutical products to key audiences here in the U.S., Bayer’s largest and fastest growing market.”

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters